Navigation Links
Targeting EETs to treat cardiovascular disease may prove a double-edged sword
Date:12/19/2011

Institutes of Health.

"NIEHS was pleased to work with such a distinguished international research team to address this important issue," Zeldin said.

With the models, the researchers were able to document that increasing the levels of EET levels either by increasing their natural production or injecting them systemically creates an environment conducive to tumor growth, even contributing to the transition of early tumors from a dormant state to active malignancy. They also found that EETs work in concert with VEGF, a potent stimulator of angiogenesis in both normal and cancerous tissues, to promote tumor metastasis, even in cancers that rarely spread to other organs.

"Many people have dormant tumors that may never become fully malignant," said Panigrahy. "The switch from a dormant to an active state is critically dependent on angiogenesis, as is metastasis, and so patients who have a high cancer risk could potentially increase that risk further by raising their EET levels."

The study team also found that compounds that block the activity of EETs, called EET antagonists, could reduce tumor growth and metastasis in the same animal models, suggesting that such compounds could have benefit as cancer treatments.

"Cardiovascular disease is a major cause of death in North America, and as such drugs that raise EET levels could provide significant benefit," says DF/CHCC's Mark Kieran, MD, PhD, one of the paper's senior authors. "We must be cautious, though, that in manipulating these molecules to regulate blood pressure we do not favor cancer growth and metastasis, another common cause of death.

"With these findings, though," Kieran continued, "we now have a better idea of how cancers drive themselves, opening up a new pathway for understanding and potentially treating cancer and metastasis that wasn't available to us before. At the same time, this data could potentially help inform the design of cardiovascular drug
'/>"/>

Contact: Children's Hospital Boston
Colleen.Connolly@childrens.harvard.edu
617-919-3110
Children's Hospital Boston
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Tumor-targeting compound points the way to new personalized cancer treatments
2. Report Slams Makers of Sugary Drinks for Targeting Kids
3. Harvard Medical School and EPFL launch program targeting neurological disabilities
4. Could targeting a virus treat a common pediatric brain tumor?
5. New bone-targeting drug delays onset of metastases in hormone-resistant prostate cancer patients
6. Targeting cholesterol may help slow glioblastoma
7. Targeting cholesterol to fight deadly brain cancers
8. Targeting innate immunity in malaria
9. Targeting PTEN may prevent skin cancer
10. Targeting the Ewing sarcoma family of tumors
11. Latest data from Cedars-Sinai vaccine study supports immune targeting of brain tumors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... As spring has sprung and summer approaches, ... increased in popularity as people finish plans for pool ... While a perennial favorite, the early Memorial Day ... weeks earlier than usual. , Similar to previous years, ... to prefer the Patio series rooms which are available ...
(Date:5/29/2015)... 2015 Healthpointe is excited to announce ... (JFT) at their clinics in Orange County. The Supartz ... assists in diminishing pain for patients with osteoarthritis, and ... and Dr. Neil Katz of Healthpointe. Supartz is an ... known as hyaluronic acid) a natural substance found in ...
(Date:5/29/2015)... 29, 2015 The report ... provides comprehensive information on the therapeutic development ... pipelines by identifying new targets and MOAs ... report on H1 2015 pipeline review of ... and 13 figures, spread across 47 pages ...
(Date:5/29/2015)... 29, 2015 Health DataPalooza is a ... to discuss and foster the most effective and innovative ... The Conference is hosted by the Health Data Consortium, ... organizations to promote and develop the use of open ... focused groups to narrow in on how to actually ...
(Date:5/29/2015)... 2015 Recently, renowned facelift specialist ... facelift surgery before the 46th National Congress of Plastic ... his presentation, Dr. Rohrich, a Dallas plastic surgeon ... Plastic Surgery at UT Southwestern Medical Center, discussed the ... they relate to obtaining long term results. , Based ...
Breaking Medicine News(10 mins):Health News:As Summer Approaches, Finnleo Notes Increased Interest in Patio and Metro Outdoor Saunas 2Health News:Healthpointe is Now Offering Supartz Joint Fluid Therapy at their Anaheim Clinic and La Mirada Clinic. 2Health News:Axillary Hyperhidrosis Therapeutic Assessment Pipeline Review H1 2015 Market Research Report Available at RnRMarketResearch.com 2Health News:Axillary Hyperhidrosis Therapeutic Assessment Pipeline Review H1 2015 Market Research Report Available at RnRMarketResearch.com 3Health News:RowdMap, Inc. Speaks on Government Health Data and Applications for Transparency, No Value Care, and Pay-for-Value Risk Arrangements at Health Datapalooza 2Health News:RowdMap, Inc. Speaks on Government Health Data and Applications for Transparency, No Value Care, and Pay-for-Value Risk Arrangements at Health Datapalooza 3Health News:Dr. Rod J. Rohrich Speaks on Longevity in Facelifts and Facial Rejuvenation 2Health News:Dr. Rod J. Rohrich Speaks on Longevity in Facelifts and Facial Rejuvenation 3
... by clinicians at the National Heart and Lung Institute, ... a novel anti-neutrophilic effect among patients with mild asthma. ... about the effects of long-acting beta2-adrenergic receptor agonists, such ... between the ages// of 18 and 55, with mild ...
... muscle wasting condition which is a serious problem in people ... the bowel, liver, lungs and heart. A recent study has ... found in fruit flies, where it is involved in muscle ... humans. ,Researchers have been studying the function of the ...
... study by researchers of Johns Hopkins University School of Medicine ... American Medical Association suggested that obesity has a marked effect ... that the risk of increased years of life lost(YLL) was ... from various National Health// and Nutrition Examination surveys. The data ...
... have found from a recent study that there is ... one cigarette in both chronic and non-smokers. The researchers ... artery properties in 185 healthy young smokers and non-smokers ... with 41 chronic smokers with their age, height, weight ...
... of Nature Biotechnology outlines a new method developed ... required for the production of industrial molecules produced ... company's ability to improve the properties// of microbial ... new technology enables the illumination of the best ...
... A new policy by the Government of India will now ... practice in India, through a screening test that will be ... of The Ministry of Health and Family Welfare). The purpose ... the Medical Council// of India or any State Medical Council ...
Cached Medicine News:
(Date:5/29/2015)... , May 29, 2015 ... the addition of the "Surgical/Operating Microscopes Market ... to 2020" report to their offering. ... surgical microscopes market is poised to reach $806.6 ... at a CAGR of 12.3% from 2015 to ...
(Date:5/29/2015)... Lilly and Company (NYSE: LLY ) and AstraZeneca ... entered into a clinical trial collaboration to evaluate the ... checkpoint inhibitor, MEDI4736, in combination with CYRAMZA ® ... planned study will assess the combination as a treatment ... Phase I study is expected to establish the safety ...
(Date:5/28/2015)... , May 28, 2015 Zimmer Holdings, ... it has finalized agreements with buyers to divest in ... Unicompartmental High-Flex Knee System assets, Biomet Discovery® Elbow System ... are in furtherance of Zimmer,s pending acquisition of Biomet, ... Zimmer continues to work constructively with the Bureau of ...
Breaking Medicine Technology:Surgical/Operating Microscopes Market by Application & End User - Global Forecast to 2020 for the $806 Million Industry 2Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 2Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 3Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 4Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 5Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 6Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 7Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 8Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 9Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 10Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 11Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 12Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 13Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 14Zimmer Announces Agreements in Furtherance of Pending Biomet Merger 2Zimmer Announces Agreements in Furtherance of Pending Biomet Merger 3Zimmer Announces Agreements in Furtherance of Pending Biomet Merger 4Zimmer Announces Agreements in Furtherance of Pending Biomet Merger 5Zimmer Announces Agreements in Furtherance of Pending Biomet Merger 6
... 4, 2011 Volcano Corporation (NASDAQ: VOLC ... diagnosis and therapy guidance tools designed to enhance the ... that it will be participating in the Bank of ... 11. The presentation by Scott Huennekens, president ...
... One Medical, Inc. ("China Sky One Medical" or "the Company") ... company in the People,s Republic of China ("PRC"), today announced ... Eastern Time (ET) on Thursday, May 12, 2011, to discuss ... Company,s quarterly report will be filed with the SEC on ...
Cached Medicine Technology:China Sky One Medical Announces Conference Call to Discuss First Quarter 2011 Results 2
The Natural-Hip combines the surgical simplicity of a straight stem with many of the best features of an anatomic stem....
The Natural-Hip combines the surgical simplicity of a straight stem with many of the best features of an anatomic stem....
The APR Hip System offers a complete line of stems to precisely match patients' anatomic needs and address surgeon preferences....
Simple straight stem design for the low-demand patient....
Medicine Products: